BERNSTEIN HAROLD (President, R&D & CMO) sold 15K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $393.4K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/18/2026ACC: 0002050172-26-000021
Officer· President, R&D & CMO
Since Mar 2026
-15K
Net shares
Net seller
$393.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$10.42
Trade value
$156.30K
% of position
New position
5/14/2026
0.00→15K
Common Stock
Direct
Shares
−15K
Price / share
$26.22
Trade value
$393.35K
% of position
New position
5/14/2026
15K→0.00
Total
Net shares
+0.00
Net value
-$237.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | M · Option Exercise | +15K | $10.42 | $156.30K | New position | 0.00 | 15K |
| Common Stock Direct | 5/14/2026 | S · Sale | −15K | $26.22 | $393.35K | New position | 15K | 0.00 |
| Total | +0.00 | -$237.05K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
10.42
Held after
222.41K
Exercisable
—
5/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 5/14/2026 | M · Option Exercise | −15K | 10.42 | — | 222.41K |